Liver Disease
122
3
6
73
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
17 trials with published results (14%)
Research Maturity
73 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.7%
13 terminated out of 122 trials
84.9%
-1.6% vs benchmark
18%
22 trials in Phase 3/4
23%
17 of 73 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 73 completed trials
Clinical Trials (122)
Evaluation of Patients With Liver Disease
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Online Prehabilitation for Patients Awaiting Liver Transplantation
Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices
Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM
Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections
Copenhagen Comorbidity in HIV Infection Study
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
Safety and Efficacy of Fecal Microbiota Transplantation
Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease
MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease
Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.
Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese